TBCCD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.872400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.634200E-01
Normal-vs-Stage2
7.546800E-01
Normal-vs-Stage3
4.647700E-02
Normal-vs-Stage4
3.779600E-01
Stage1-vs-Stage2
8.276600E-01
Stage1-vs-Stage3
5.650400E-02
Stage1-vs-Stage4
2.322200E-01
Stage2-vs-Stage3
4.442400E-02
Stage2-vs-Stage4
6.875700E-02
Stage3-vs-Stage4
3.588000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.609600E-01
Normal-vs-AfricanAmerican
8.407800E-01
Normal-vs-Asian
5.469400E-01
Caucasian-vs-AfricanAmerican
7.948600E-01
Caucasian-vs-Asian
6.928200E-01
AfricanAmerican-vs-Asian
6.710000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.789000E-01
Normal-vs-Female
8.124000E-01
Male-vs-Female
1.837820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.107800E-01
Normal-vs-Age(41-60Yrs)
8.128000E-01
Normal-vs-Age(61-80Yrs)
4.768200E-01
Normal-vs-Age(81-100Yrs)
3.090600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.457400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.291600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.890600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.647800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.049800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.102000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.579600E-01
Normal-vs-Daily Drinker
3.362000E-01
Normal-vs-Weekly Drinker
6.549600E-01
Normal-vs-Occasional Drinker
8.362800E-01
Normal-vs-Social Drinker
9.417800E-01
Non Drinker-vs-Daily Drinker
3.695200E-01
Non Drinker-vs-Weekly Drinker
8.442000E-01
Non Drinker-vs-Occasional Drinker
4.689400E-01
Non Drinker-vs-Social Drinker
3.347800E-01
Daily Drinker-vs-Weekly Drinker
3.672400E-01
Daily Drinker-vs-Occasional Drinker
1.518820E-01
Daily Drinker-vs-Social Drinker
1.037780E-01
Weekly Drinker-vs-Occasional Drinker
6.741200E-01
Weekly Drinker-vs-Social Drinker
5.217200E-01
Occasional Drinker-vs-Social Drinker
8.087000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.554600E-01
Normal-vs-Grade 2
3.189900E-02
Normal-vs-Grade 3
5.221500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.728440E-02
Grade 1-vs-Grade 3
9.483200E-03
Grade 1-vs-Grade 4
3.554600E-01
Grade 2-vs-Grade 3
5.823000E-01
Grade 2-vs-Grade 4
3.189900E-02
Grade 3-vs-Grade 4
5.221500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.680400E-01
Normal-vs-NonDiabetic
6.065800E-01
Diabetic-vs-NonDiabetic
6.407600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.590000E-01
Normal-vs-NoPancreatitis
6.306400E-01
Pancreatitis-vs-NoPancreatitis
6.392400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.174200E-01
Normal-vs-N1
8.021400E-01
N0-vs-N1
1.661440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.883800E-01
Normal-vs-TP53-NonMutant
6.487800E-01
TP53-Mutant-vs-TP53-NonMutant
1.037840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
